JPMorgan added PTC Therapeutics to its list of favorite stocks as the new month gets underway. Every month, the bank refreshes its analyst focus list, which includes top ideas from JPMorgan analysts aligned with growth, income, value and short investment strategies. The bank's changes come after stocks notched a solid performance in August , which is a historically weak month for the major benchmarks. Lifting investors' spirits heading into September is optimism that the Federal Reserve will finally begin to cut rates at its meeting this month. The CME FedWatch Tool shows the market has now priced in a nearly 90% chance of this happening. Additions over the past four weeks to JPMorgan's focus list included ACV Auctions , Cellebrite , McCormick , PTC Therapeutics and Armstrong World Industr

See Full Page